https://www.selleckchem.com/products/gdc-0994.html
Pts with a CR had lower mean metabolic tumor volume on baseline FDG-PET/CT scan (CR 35.7 mL, no CR 187.8 mL, p=0.05). There was no correlation between PD-L1 positivity and MCPyV status (p=0.764) or OR (p=0.245). 10 pts received radiation therapy (RT) during ICI 4 pts started RT concurrently (OR 75%, CR 50%), 3 pts had isolated ICI-resistant lesions successfully treated with RT and 3 pts with multisite progression continued to progress despite RT. Overall, 6 pts (26%) had grade 1-2 immune-related adverse events. ICIs showed efficacy and